Study on analgesic effect of Tramadol Hydrochloride injection in patients with tongue carcinoma after surgery

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000041419

Enrollment

Unknown

Registered

2020-12-25

Start date

2021-01-01

Completion date

Unknown

Last updated

2021-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tongue cancer

Interventions

experimental group:Intramuscular injection of tramadol hydrochloride was performed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients aged from 14 to 75, regardless of gender; 2. Patients who have been diagnosed with tongue cancer and need relevant surgery; 3. The patients who volunteer to be tested and sign the informed consent of patients.

Exclusion criteria

Exclusion criteria: 1. Patients with severe hepatic and renal insufficiency; 2. Patients who have participated in other clinical trials within 3 months; 3. Patients with mental illness (epilepsy) or unable to cooperate.

Design outcomes

Primary

Measure	Time frame
VAS score;	—

Countries

China

Contacts

Public ContactLi Chunjie

West China Stomatological Hospital of Sichuan University

lichunjie@scu.edu.cn+86 18382439003

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026